---
title: "Synthetic biology concept stocks fluctuated and rose, Yili Chuanning Bio hit a 20% limit up"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/240269276.md"
description: "Synthetic biology concept stocks fluctuated and rose, Yili Chuanning Bio hit a 20% limit up, Bawei Co., Ltd. rose over 20%, Tuoxin Pharmaceutical rose over 10%, Kingdomway, Ocon Pharmaceutical, and Vland Biotech followed suit"
datetime: "2025-05-15T01:55:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/240269276.md)
  - [en](https://longbridge.com/en/news/240269276.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/240269276.md)
generator: "portal-rs"
---

# Synthetic biology concept stocks fluctuated and rose, Yili Chuanning Bio hit a 20% limit up

Synthetic biology concept stocks fluctuated and rose, Yili Chuanning Bio hit the 20% daily limit, Bawei Co., Ltd. rose over 20%, Tuoxin Pharmaceutical rose over 10%, Kingdomway, Ocon Pharmaceutical, and Vland Biotech followed suit

### Related Stocks

- [301301.CN](https://longbridge.com/en/quote/301301.CN.md)
- [002626.CN](https://longbridge.com/en/quote/002626.CN.md)
- [603739.CN](https://longbridge.com/en/quote/603739.CN.md)
- [301089.CN](https://longbridge.com/en/quote/301089.CN.md)

## Related News & Research

- [Promise Analyzes Telehealth Licensing Rules as Compact Hits Record 3,633 Licenses in a Month](https://longbridge.com/en/news/296635882.md)
- [Nasdaq Futures Plunge as Rising Bond Yields Drive Chip Selloff](https://longbridge.com/en/news/296216952.md)
- [Frozen blueberries recall categorized under FDA's highest Class I risk level](https://longbridge.com/en/news/296506599.md)
- [Orkla Non-GAAP EPS of NOK 1.60, revenue of NOK 16.7B](https://longbridge.com/en/news/296456178.md)
- [Kona BidCo raises Zalaris stake to 87.34% after buying 2,337 shares at NOK 100 apiece](https://longbridge.com/en/news/296256150.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**